挥舞 发表于 2025-3-23 12:44:34

978-1-4612-8974-6Kluwer Academic Publishers, Boston 1988

玛瑙 发表于 2025-3-23 17:54:36

Endocrine Therapies in Breast and Prostate Cancer978-1-4613-1731-9Series ISSN 0927-3042 Series E-ISSN 2509-8497

DEBT 发表于 2025-3-23 21:12:55

Cancer Treatment and Researchhttp://image.papertrans.cn/e/image/309733.jpg

茁壮成长 发表于 2025-3-23 22:45:29

http://reply.papertrans.cn/31/3098/309733/309733_14.png

Intellectual 发表于 2025-3-24 06:10:58

http://reply.papertrans.cn/31/3098/309733/309733_15.png

kindred 发表于 2025-3-24 08:29:59

http://reply.papertrans.cn/31/3098/309733/309733_16.png

绅士 发表于 2025-3-24 11:17:15

http://reply.papertrans.cn/31/3098/309733/309733_17.png

吊胃口 发表于 2025-3-24 17:31:19

Representations of Childhood Deathnts, and estrogen therapy may be associated with fluid retention, thromboembolic complications, gynecomastia, and gastrointestinal side effects. Therefore, an effective systemic therapy readily acceptable to all patients and without side effects remains a desirable goal. Antiandrogens are one of sev

nonplus 发表于 2025-3-24 21:04:40

http://reply.papertrans.cn/31/3098/309733/309733_19.png

注意 发表于 2025-3-25 03:05:49

Preclinical Studies and Antitumor Mechanism of Action of LHRH Analogues,o suppress ovarian activity, reduce circulating levels of estradiol, and cause a decrease in size of estrogen target tissue , including an ability to promote extensive regressions in estrogen receptor-positive, dimethylben-zanthracene-induced mammary tumours . Similarly, in male animals, LH
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Endocrine Therapies in Breast and Prostate Cancer; C. Kent Osborne Book 1988 Kluwer Academic Publishers, Boston 1988 carcinoma.cell.clinic